Dupilumab as a novel steroid-sparing treatment for hypereosinophilic syndrome.
Du X, Chen Y, Chang J, Sun X, Zhang Y, Zhang M, Maurer M, Li Y, Zhao Z, Tong X.
Du X, et al. Among authors: zhang m, zhang y.
JAAD Case Rep. 2022 Mar 17;29:106-109. doi: 10.1016/j.jdcr.2022.03.017. eCollection 2022 Nov.
JAAD Case Rep. 2022.
PMID: 36217427
Free PMC article.
No abstract available.